MAR 10, 2021 7:00 AM PST

What's Your Type? Skin Microbes Linked to Dermatitis Severity.

WRITTEN BY: Tara Fernandez

Microbiologists have discovered that the types of bacteria on a dermatitis patient’s skin affect the severity of the irritating skin condition. Variations in the types and numbers of microbes on the skin could explain why some suffer from more severe forms of skin disease.

One in five people worldwide has atopic dermatitis, an umbrella term used to describe skin conditions such as eczema. Taking a closer look at these patients’ skin microbiome signatures could provide vital clues to aid in diagnostics and designing appropriate strategies to manage the condition.

Researchers at the Skin Research Institute of Singapore studied the skin microbiome from a cohort of patients who attended a specialist treatment center for their condition.

 

 

They found two distinct types of microbial signatures, called Dermotypes A and B. The B type was linked to more intense and frequent flare-ups and significantly more itching. Interestingly, the microbial ecosystems on Dermotype B patients had less diversity in terms of the friendly microbial colonizers. They also observed differences in the metabolic capacity of type B bugs, which was linked to a spike in pathogenic virulence genes.

“Interestingly, when we integrated our data on the skin microbiome, host immunity and skin barrier function, we show that the dermotypes provide a link to a mechanism for microbiome-driven inflammation and increased disease severity,” said study author Niranjan Nagarajan.

These results help classify dermatitis patients according to their specific needs and could even open the door to innovative treatment approaches. By therapeutically altering the dermotype state, patients may experience relief from their symptoms and possibly even restoration of the skin’s homeostasis.

 

Sources: A*STAR Research, The Journal of Allergy and Clinical Immunology


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 27, 2021
Clinical & Molecular DX
No Pain, All the Diagnostic Gain
JAN 27, 2021
No Pain, All the Diagnostic Gain
A recent study published in Nature Biomedical Engineering describes new microneedle patch technology that takes the &ldq ...
FEB 11, 2021
Clinical & Molecular DX
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
FEB 11, 2021
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
Only around half of women diagnosed with breast cancer will benefit from hormonal therapy, a cancer treatment that adds, ...
MAR 09, 2021
Cardiology
A Lifestyle Change Could Reduce a Diabetic's Cardiovascular Risk
MAR 09, 2021
A Lifestyle Change Could Reduce a Diabetic's Cardiovascular Risk
Nowadays, everyone thinks there is a pill or gummy that will fix everything. That may be true for the occasional headach ...
MAR 23, 2021
Cell & Molecular Biology
One Metabolic Problem May Cause Multiple Diseases
MAR 23, 2021
One Metabolic Problem May Cause Multiple Diseases
Patients with a disease often see specialists, and there may not be much communication among them when individuals suffe ...
APR 09, 2021
Cell & Molecular Biology
CRISPR-SNP Chip Finds Point Mutations in DNA Without PCR
APR 09, 2021
CRISPR-SNP Chip Finds Point Mutations in DNA Without PCR
Some diseases, like sickle-cell anemia and familial amyotrophic lateral sclerosis are due to errors in only a single let ...
APR 20, 2021
Cardiology
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
APR 20, 2021
Does Impaired Glucose Tolerance Increase Heart Damage After a Stroke?
Diabetes is a looming threat to the world’s healthcare systems. Diagnoses of its precursors, impaired glucose tole ...
Loading Comments...